24/7 Wall Street
27 Oct 2026, 18:40 UTC · 1h ago
Rocket Lab Is Still Down 17% in 2026: Did RKLB Stock Just Find a Bottom?
Impact · against what's priced in
The news is largely neutral for the space operators as the market has already discounted their execution risks and dilution. While Rocket Lab shows strong revenue growth and a record backlog, these figures are already factored into the current valuation, and the Iridium acquisition remains a pending catalyst rather than a realized gain.
- PL+0.00
Already priced in
- The price assumes
Severe dilution risk from the $1.5 billion at-the-market equity facility





